Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ZG-2291
Cat. No.:
OB0425LY-214
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
ZG-2291 is a selective inhibitor targeting FIH that enhances thermogenesis in ob/ob mice.
Synonyms:
ZG2291; 2-[[5-[3-(3-Chlorophenyl)-1,2-oxazol-5-yl]-3-oxidanyl-pyridin-2-yl]carbonylamino]ethanoic acid; 3-Hydroxy-5-(3-m- chlorophenylisoxazol- 5-yl)picolinoyl glycine; N-({5-[3-(3-Chlorophenyl)-1,2-oxazol-5-yl]-3-hydroxypyridin-2-yl}carbonyl)glycine; [({5-[3-(3-Chlorophenyl)-1,2-oxazol-5-yl]-3-hydroxypyridin-2-yl}carbonyl)amino]acetic acid; 2962103-40-6
CAS No.:
2962103-40-6
Compound CID:
170066128
Formula:
C17H12ClN3O5
Formula Weight:
373.75
Specification
Target:
HIF/HIF prolyl-hydroxylase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
ZG-2291 can be used to improve obesity-related symptoms and metabolic dysfunctions.
